Clinical effectiveness of liraglutide on weight loss in South Koreans: First real-world retrospective data on Saxenda in Asia

Among Asian countries, South Korea was the first to approve liraglutide as a treatment for obesity. Thus, the clinical effectiveness of liraglutide has not been studied in Asian populations. In this study, we retrospectively analyzed obese patients [body mass index (BMI) >27 kg/m(2)] who were tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joon Seok, Kwon, Jieun, Choi, Hyung Jin, Lee, Changhyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808520/
https://www.ncbi.nlm.nih.gov/pubmed/33466127
http://dx.doi.org/10.1097/MD.0000000000023780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808520/
https://www.ncbi.nlm.nih.gov/pubmed/33466127
http://dx.doi.org/10.1097/MD.0000000000023780

Ejemplares similares